Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Foerde – page 7

88 clinical trials in Foerde, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Foerde at a glance
88
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

88 trials in Foerde

Open in trial search

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Myokardia Inc.

Rheumatoid arthritis

Not recruiting

Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Diakonhjemmet Sykehus AS

Breast cancer

Not recruiting

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Asthma

Not recruiting

Study on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Irinotecan
  • Sponsor:Pharma Mar S.A.

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Femur fracture+1

Not recruiting

Study on Methadone and Placebo for Pain Relief in Elderly Patients with Hip Fractures

Registered drug
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Sodium Chloride
  • Sponsor:Sygehus Soenderjylland Soenderborg

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Multiple sclerosis

Not recruiting

Study on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Natalizumab
  • Sponsor:Helse Bergen HF

Cardiac arrest

Not recruiting

Study on Sodium Bicarbonate and Sodium Chloride for Patients with In-Hospital Cardiac Arrest

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Midtjylland

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Foerde

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on precision cancer medicine for rare and hard-to-treat cancers, including targeted therapy approaches and personalized treatment strategies.

  • Breast Cancer Molecular Studies
  • Advanced Non-Small Cell Lung Cancer
  • Multiple Myeloma Treatments

Studies aim to identify treatment response markers and evaluate novel therapeutic combinations.

02 Hematological Studies

Research focusing on blood disorders and blood-related cancers, with emphasis on developing treatment options for patients unsuitable for standard chemotherapy.

  • Acute Myeloid Leukemia
  • Multiple Myeloma
  • High-Risk Myelodysplastic Syndrome

Trials evaluate combination therapies and novel treatment approaches for better patient outcomes.

03 Neurological & Autoimmune Conditions

Studies examining new therapeutic approaches for multiple sclerosis and rheumatoid arthritis, focusing on drug monitoring and treatment optimization.

  • Multiple Sclerosis Management
  • Rheumatoid Arthritis Control
  • Drug Response Monitoring

Research aims to improve disease control and treatment effectiveness through proactive monitoring.

04 Specialized Medical Research

Diverse clinical investigations including studies on sudden hearing loss and pain management in cancer patients.

  • Hyperbaric Oxygen Therapy
  • Pain Management Studies
  • Therapeutic Drug Monitoring

Focus on improving treatment outcomes through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.